Medical/Pharmaceuticals
/C O R R E C T I O N -- CooperVision, Inc./
In the news release, CooperVision Expands MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses Into Asia Pacific Region, issued 02-Mar-2026 by CooperVision, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with addition...
2026-03-03 10:27
6976
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan St...
2026-03-03 10:15
4585
The largest pharma show in Asia makes its return to Shanghai this June 2026
SHANGHAI, March 2, 2026 /PRNewswire/ -- CPHI & PMEC China 2026 is set to take place from 16 to18 June 2026 at the Shanghai New International Expo Centre (SNIEC), building on its extremely successful run over the last few years. As the world's premier destination for pharmaceutical ingredients and...
2026-03-03 10:15
3113
Bright Eye Clinic Achieves Government Accreditation Amid Korea's Medical Tourism Growth
SEOUL, South Korea, March 3, 2026 /PRNewswire/ -- Bright Eye Clinic
2026-03-03 10:00
3457
AsiaMedic Delivers Improved FY2025 Performance as Core Imaging Business Strengthens
* Financial performance strengthened alongside business expansion as newly added capacity are ramped up during the year * Profit attributable to owners of the Company doubled to S$2.0 million in FY2025 * Disposal of 60% interest in aesthetic business sharpens focus on core healthcare operat...
2026-03-03 09:40
5009
Efor strengthens its presence in Asia with the acquisition of No deviation
LYON, France, March 3, 2026 /PRNewswire/ -- Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer S...
2026-03-03 09:00
4469
US BioTek Laboratories Completes Merger With NutriPATH Pathology
SEATTLE and MELBOURNE, Australia, March 3, 2026 /PRNewswire/ -- US BioTek Laboratories, a leading functional laboratory specializing in advanced immunological and integrative diagnostics, today announced the completion of its merger with NutriPATH Pathology, a respected functional pathology labo...
2026-03-03 02:15
4299
Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Australia's Therapeutic Goods Administration (TGA), responsible for approval of the safety, quality, and efficacy of therapeutic goods, has determined that Skyhawk's SKY-0515 orally-administered small molecule therapy for the treatment of Huntington's disease meets TGA eligibility criteria for re...
2026-03-03 01:20
4790
The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation
International Prize Honors Trailblazing Work Advancing Psychoanalytic Thought and Principles — Cash Award and Global Recognition SAN FRANCISCO, March 2, 2026 /PRNewswire/ -- The Sigourney Award Trust welcomes applications for The Sigourney Award-2026 from individuals, teams, and organizations wo...
2026-03-02 22:49
3180
XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy
SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart)announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its independently developed, off-the-shelf, allogeneic, uni...
2026-03-02 22:10
3742
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly announced positive topline results from a Phase II clinical trial of it...
2026-03-02 22:00
3483
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven RNA-modulating small molecules to treat rare an...
2026-03-02 22:00
4130
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company presentation at the BIO Investment & Growth Summit. David Bearss, Ph.D., Chief Executive Officer ...
2026-03-02 21:35
3513
The largest pharma show in Asia makes its return to Shanghai this June 2026
SHANGHAI, March 2, 2026 /PRNewswire/ -- CPHI & PMEC China 2026 is set to take
place from16 to 18 June 2026 at the Shanghai New International Expo Centre
(SNIEC), building on its extremely successful run over the last few years.
2026-03-02 20:09
3695
ECR 2026: Esaote Group Introduces Breakthroughs in Ultrasound, MRI and Enterprise Imaging
The new MyLab™E85 GTS and MyLab™C30 GTS Edition ultrasound systems will be presentedon Thursday, 5th March at 11.30 a.m. at the Esaote Booth GENOA, Italy, March 2, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging – ultrasound, dedicated magnetic resonance and med...
2026-03-02 19:30
3961
COLUMBIA ASIA HOSPITAL BUKIT JALIL LAUNCHES NEW CATH LAB TO STRENGTHEN HEART CARE SERVICES
The new cardiac catheterisation facility enables faster, minimally invasive treatment and improved access to specialist care, closer to home. KUALA LUMPUR, Malaysia, March 2, 2026 /PRNewswire/ -- Columbia Asia Hospital Bukit Jalil has officially launched its new Cardiac Catheterisation Laboratory...
2026-03-02 14:24
12394
WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year
SHANGHAI, March 1, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been included in the S&P Global Sustainability Yearbook 2026 ("Yearbook") in recognition of its strong performance in the 2025...
2026-03-02 11:21
4221
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three indications across MM and diffuse large B-cell lymphoma...
2026-03-02 08:30
3785
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
SAN FRANCISCO and SUZHOU, China, March 1, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabol...
2026-03-02 08:00
4061
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis
SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III ...
2026-03-02 08:00
3862
Week's Top Stories
Most Reposted
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
Indonesia's P2P Lending Grows 25%, JULO Strengthens Credit Quality
[Picked up by 299 media titles]
2026-03-26 18:18
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 277 media titles]
2026-03-25 16:51
Most Read
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7925
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7696
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7674
U Power Limited Announces Closing of $6.0 Million Public Offering
2026-03-21 02:40
7228